Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors.
Pertwee
R G
RG
Department of Biomedical Sciences, University of Aberdeen, Foresterhill, Scotland, U.K.
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D002186:Cannabinoids / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D005459:Fluorides / Q000378:metabolism; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000187:drug effects / Q000378:metabolism*; D013849:Thimerosal / Q000494:pharmacology
D000477:Alkylating Agents; D002186:Cannabinoids; D005227:Fatty Acids; D007783:Lactones; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D013849:Thimerosal; D005459:Fluorides; D007052:Ibuprofen